Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To investigate the growth inhibition effect of the combination of bcr/abl phosphorothioate antisense oligonucleotides (PS-ASODN) and curcumin (cur), and the possible mechanisms of cur on the chronic myelogenous leukemia cell line K562.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Acta Pharmacol Sin

Title: Acta pharmacologica Sinica

Publisher: Wiley

ISSN: 1671-4083

ISSN (Print): 1671-4083

Publication date (Electronic): Jan 2007

Volume: 28

Issue: 1

Affiliations

[1 ] Institute of Clinical Pharmacology, School of Pharmacy, Fujian Medical University, Fujian 350004, China. xjh@mail.fjmu.edu.cn.

Article

DOI: 10.1111/j.1745-7254.2007.00471.x

PubMed ID: 17184589

SO-VID: 5bf314ec-6578-432e-a257-aea6efe40584

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 3

See all cited by